Skip to main content
. Author manuscript; available in PMC: 2018 Mar 12.
Published in final edited form as: Vaccine. 2015 Jun 10;33(32):4025–4034. doi: 10.1016/j.vaccine.2015.05.088

Table 1.

Demographic characteristics of enrolled participants.

M72/AS01E (n = 40) Placebo (n = 20) Overall (n = 60)
Male, n (%) 22 (55.0) 9 (45.0) 31 (51.7)
Median age in years (range, IQRa) 15.0 (13–17, 14–16) 14.5 (14–17, 14–15) 15.0 (13–17, 14–16)
Race, n (%)
 Black 11 (27.5%) 6 (30.0%) 17 (28.3%)
 White 3 (7.5%) 1 (5.0%) 4 (6.7%)
 Mixed race 26 (65.0%) 13 (65.0%) 39 (65.0%)
QuantiFERON status at baseline, n (%)
 Negative 22 (55.0%) 10 (50.0%) 32 (53.3%)
 Positive 18 (45.0%) 10 (50.0%) 28 (46.7%)
a

IQR, Interquartile range.

n (%) = number (percentage) of participants enrolled.